BioSig, Biotech Stock Review

BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems

Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence Westport,...
Dalrada

Dalrada (DFCO) Finally Pops. Up 59% Today.

Up 59% today on news and with 4 million shares trading and counting! LIVE QUOTE
Hapbee

Adding Hapbee (HAPB) to the Watch List.

Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...
Hapbee

Hapbee’s (HAPB) Device, “Choose How You Feel.”

HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL' Proprietary, Research-Backed...

Kevin Harrington Presentation. (Video)

The Three Strategies I've Used to Build Businesses. https://youtu.be/aNZAAKxPNlM Shark Tanks’ Kevin...
Mark Washo, Aphex Biocleanse

Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...

PITTSFORD, N.Y., Nov. 12, 2020 PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...
OMNIQ

OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.

OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year
Hapbee

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Hapbee Provides Update on Recent Corporate Developments - Manufactured and Shipped Over 1,800 Hapbee Wearables to Early Adopters, Fulfilled All Orders from...
Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared...
Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price...

Latest article

Citius, Biotech Stock Review

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...
Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...

Video: Pacific Stem Cell

With nearly a third of the US suffering from chronic pain, and over a million patients a year having joint replacements, affordable...